Solana (SOL) traded at $141.67 with a $59.8B market cap, fueled by heightened ETF approval speculation. Invesco’s QSolana (SOL) ETF filing and REX Shares’ REX-Osprey Solana (SOL) Staking ETF, set to ...

In the wake of the catastrophic Texas floods, officials want the public to understand disaster response, rescue and recovery operations.

A proposed layout for the initial phase of Rochester's planned sports and recreation complex has been finalized. The Rochester City Council will be asked Monday to approve the schematic design of ...

Marvel Studios' Phase 5 came to an end with Ironheart last week, and we're reflecting on this tumultuous chapter in the ...

After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...

FTAI Infrastructure’s first quarter saw year-on-year revenue growth, though results came in below Wall Street’s sales ...

NIO trades far below its 5-year P/S average, but high costs and ONVO struggles cloud its improving delivery outlook.

New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...

Milestone Pharmaceuticals Inc. is a strong buy under $2 with FDA approval for Cardamyst expected in 2026, offering unique ...

Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral ...

A former top bureaucrat who worked closely with Treasurer Jim Chalmers wants boomers to be hit with a new tax on their ...

Wave Life Sciences could offer significant upside if obesity candidate WVE-007 delivers strong human data. Check out the ...